HS

Encompass Health CorpFRA Encompass Stock Report

Last reporting period 30 Sep, 2024

Updated 21 Nov, 2024

Last price

Market cap $B

9.586

Middle

Exchange

XFRA - Deutsche Boerse AG

HSOA.F Stock Analysis

HS

Avoid

Based on Eyestock quantitative analysis, HSOA.F`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

71/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-12.7 %

Greatly overvalued

Market cap $B

9.586

Dividend yield

0.64 %

Shares outstanding

99.788 B

Encompass Health Corporation is a provider of post-acute healthcare services. The Company manages its operations through its inpatient rehabilitation segment. It is an owner and operator of inpatient rehabilitation hospitals. The Company has a national network of inpatient rehabilitation hospitals stretches across 35 states and Puerto Rico, with a concentration of hospitals in the eastern half of the United States and Texas. It provide specialized rehabilitative treatment on both an inpatient and outpatient basis. Its advanced therapies include physical therapy, occupational therapy and speech therapy. The Company offers rehabilitative care to patients and the ones recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

View Section: Eyestock Rating